X-linked myotubular myopathy is associated with significant mortality and healthcare burden.
No takes yet. Share an insight, caveat, or question.
XLMTM carries high mortality and resource use; leaves open optimal management and therapy development.
Beggs et al. (2017) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: